• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Vaccines, Blood & Biologics

  • Print
  • Share
  • E-mail

7/3/2007 Telecon - RECOTHROM

FOOD AND DRUG ADMINISTRATION
CENTER FOR BIOLOGICS EVALUATION AND RESEARCH

Telecon

Date: July 3, 2007
To: File STN 125248/0 ZymoGenetics Thrombin (Recombinant)
From: Mark A. Shields, HFM-380; RPMB, DBA, OBRR, CBER; (301) 827-6173 FAX (301) 827-2857
Subject: 02-Jul-07 Telecon.

FDA Attendees: Mark Shields

ZymoGenetics Participants:
Dale Goodloe.

Discussion Points;

I called Mr. Goodloe to request he email me the names of the ZymoGenetics participants in the telecom held yesterday (02-Jul07). I also requested he submit their version of meeting minutes as an amendment to the BLA for the record.

He agreed to provide.

END

 

Contact FDA

(800) 835-4709
(301) 827-1800
Consumer Affairs Branch (CBER)

Division of Communication and Consumer Affairs

Office of Communication, Outreach and Development

Food and Drug Administration

1401 Rockville Pike

Suite 200N/HFM-47

Rockville, MD 20852-1448